Last Updated on November 6, 2024 by The Health Master
India has initiated an anti-dumping investigation into imports of dicyclohexylcarbodiimide (DCC) from China, following a complaint filed by a domestic firm.
The commerce ministry’s investigation arm Directorate General of Trade Remedies (DGTR) is probing alleged dumping of DCC, widely used in medical, health, make-up and biological products, from China.
It is a key raw material in antiretroviral drugs like valaliclovir and amikacin.
This product is mainly used in amikacin, glutathione dehydrants, as well as in the synthesis of acid anhydride, aldehyde, ketone, isocyanate. It is also used in the synthesis of peptides, esters, ethers, nitriles etc.
Clean Science and Technology Pvt Ltd has filed an application before the DGTR seeking initiation of anti-dumping investigation concerning imports of DCC from China.
Also read:
Special teams to be formed to bust fake drug racket: AP
IPC issues clarification on alternative medicine in IP
Chinese hackers target these Indian Vaccine makers
The applicant has alleged that material injury is being caused to the domestic industry due to dumped imports from the subject country and has requested for the imposition of the anti-dumping duties on the imports.
The applicant claimed that an increase in imports of DCC from China at a price below selling price has adversely impacted production, sales and profits of domestic industry.
There is prima facie evidence that the product from the subject country is being dumped into the Indian market by the exporters from the subject country and consequent materially retardation to the nascent domestic industry, it said.
“On the basis of the duly substantiated written application by or on behalf of the domestic industry, and having satisfied itself, on the basis of the prima facie evidence submitted, about dumping of the subject goods the authority, hereby, initiates an investigation,” stated a notification issued by DGTR.
In the probe, the DGTR will determine the existence, degree and effect of alleged dumping and then recommend the quantum of anti-dumping duty, which if levied, would be “adequate” to remove the injury to the domestic industry.
The period of investigation is January 1, 2020 to December 31, 2020, including data from April 2017 onwards.
Countries initiate anti-dumping probes to determine if the domestic industry has been hurt by a surge in cheap imports. As a counter-measure, they impose duties under the multilateral WTO regime.
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
